RGIN OTC
Regenicin, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -66.7%
1Y: +0.0%
3Y: -97.1%
5Y: -99.2%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$601K
+0.0% ▲
Operating Income
-$601K
+5.5% ▲
Net Income
-$639K
+4.7% ▲
EPS (Diluted)
$-0.00
+6.2% ▲
EBITDA
-$601K
+5.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $601K |
| Gross Profit | $0 | $0 | $0 | $0 | -$601K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $789K | $737K | $664K | $842K | $601K |
| Operating Expenses | $789K | $737K | $511K | $636K | $601K |
| Operating Income | -$540K | -$737K | -$511K | -$636K | -$601K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $19K | $18K | $47K | $35K | $36K |
| Income Before Tax | -$559K | -$758K | -$560K | -$671K | -$639K |
| Tax Expense | -$789 | $18K | $0 | $0 | $0 |
| Net Income | -$559K | -$758K | -$560K | -$671K | -$639K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.00 | $-0.01 | $-0.00 | $-0.00 | $-0.00 |
| EBITDA | -$789K | -$737K | -$511K | -$636K | -$601K |
| Shares Outstanding | 153M | 153M | 153M | 153M | 153M |